Nasdaq

Medtronic INVOS™ 7100 Cerebral/Somatic Oximetry System receives 510(k) clearance for pediatric indications

FDA clearance expands use of the INVOS™ 7100 system, helping clinicians better monitor organ-specific oxygen levels and identify warnings signs for neonates and children earlier "Timing is critical ...
Nasdaq

Medtronic's (MDT) INVOS System Gets FDA 510 (k) Clearance

Medtronic plc MDT recently announced the receipt of the FDA 510 (k) clearance for its INVOS 7100 cerebral/somatic oximetry system for children from birth to age 18. The INVOS 7100 system with ...
Business Wire

GE Healthcare, Medtronic Partnership Accelerates Global Access to Personalized Care by Delivering Advanced Patient Monitoring Solutions on the CARESCAPE Platform

GE Healthcare, Medtronic receive FDA 510(k) clearance and CE Mark approval on the integration of advanced INVOS™ regional oximetry and Microstream™ capnography technologies on the CARESCAPE precision ...
Becker's Hospital Review

INVOS regional oximetry in cardiac surgery outcomes: A valuation analysis

Several hospitals are conducting an analysis of how monitoring cerebral oximetry during open heart surgery impacts patient outcomes and their related costs. More high-risk, high-liability patients are ...
Becker's Hospital Review

Education, standardized interventions and accountability: How continual electronic monitoring improves patient outcomes

As hospital reimbursement becomes more closely linked to quality outcomes, clinical and administrative leaders are looking for the right tools to standardize training and intervention protocols to ...